CCR6 and COVID-19: Similar data were obtained using molecular biology methods, which revealed that peripheral blood CD4+ T cells from patients with severe COVID-19 had downmodulated expression of Th17-associated genes, e.g., RORC, IL17A, IL17F, and CCR6 (151).